Business Description
Longeveron is a Miami-based medical research company focused on developing stem cell treatments for serious diseases linked to aging and heart defects. Its primary product, LOMECEL-B, is derived from the bone marrow of healthy young adults and is currently being tested in multiple clinical trials targeting conditions such as a rare heart disorder in children, Alzheimer's disease, and physical decline in older adults. Founded in 2014, the company continues to advance its research pipeline toward potential regulatory approval.
